تحميل...

Plasma methoxytyramine: A novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumor size, location and SDHB mutation status

BACKGROUND: There are currently no reliable biomarkers for malignant pheochromocytomas and paragangliomas (PPGLs). This study examined whether measurements of catecholamines and their metabolites might offer utility for this purpose. METHODS: Subjects included 365 patients with PPGLs, including 105...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Eisenhofer, Graeme, Lenders, Jacques W.M., Siegert, Gabriele, Bornstein, Stefan R., Friberg, Peter, Milosevic, Dragana, Mannelli, Massimo, Linehan, W. Marston, Adams, Karen, Timmers, Henri J., Pacak, Karel
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	2011
الموضوعات:	Article
الوصول للمادة أونلاين:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3372624/ https://ncbi.nlm.nih.gov/pubmed/22036874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2011.07.016
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

Plasma methoxytyramine: A novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumor size, location and SDHB mutation status

مواد مشابهة